XtRNA Bio

Netherlands
Nieuw-Amsterdam, Drenthe, The Netherlands, 1105 BP

Company profile

XtRNA Bio company profile

XtRNA Bio is developing a new class of RNA therapeutics targeting genetic diseases caused by translation defects.

Business identity

Operating status
Active

Headquarters

Postal code
1105 BP
Country code
NL
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
1
Last funding
Series Unknown / 2025-06-24
Last equity funding
Series Unknown
Investors
1
Lead investors
1

Categories and groups

Founders and investors

Lead investors

CMT Research Foundation

Investors

CMT Research Foundation